A carregar...
Potential Adiponectin Receptor Response Modifier Therapeutics
Many human diseases may benefit from adiponectin replacement therapy, but due to pharmacological disadvantages of the intact protein, druggable options focus on peptidic, and small molecule agonists of the adiponectin receptor. Peptide-based adiponectin replacement drug leads are derived from, or re...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700268/ https://ncbi.nlm.nih.gov/pubmed/31456747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00539 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|